Anavex Life Sciences Corp (AVXL)

[TempePhil]

Reasons for no A2-73 peer reviewed article...
I was very disappointed to learn there would be no peer reviewed article. I was looking forward to seeing all the most recent data and have many details explained.

I think the reasons it was not published are as follows:

It seems that, almost monthly, the understanding of the science of a2-73 efficacy increases. Not just s1R, but homeostasis, autophagy, gut biome, gaba/glutamate, etc.

Because of the ever increasing understanding, Dr.Missling probably did not want to publish, as it would appear to be published early, before the knowledge/project was complete. Scientists do not like to publish partial results!

Also within 6 months (at the time) rett and PD trial results were expected, and the results would generate the desired PR/interest.

Also, companies are sensitive to publishing their R&D results for the world. There is little upside, and the downside is the releasing of what are called 'industrial secrets'.

Lastly, the team has been busy preparing trials, expansions, partnering, etc. These efforts obviously should have higher priority!

I know interest has waned, on this subject, but I wanted to publish my thoughts. Xena might include the topic when she writes her book on the great success story of Anavex!